Comparative molecular docking and simulation analysis of molnupiravir and remdesivir with SARS-CoV-2 RNA dependent RNA polymerase (RdRp)

Treatment of SARS-CoV-2 targeting its RNA dependent RNA polymerase (RdRp) is of current interest. Remdesivir has been approved for the treatment of COVID-19 around the world. However, the drug has been linked with pharmacological limitations like adverse effects and reduced efficiency. Nevertheless,...

Descripción completa

Detalles Bibliográficos
Autores principales: Patil, Shashank M, Maruthi, KR, Bajpe, Shrisha Naik, Vyshali, VM, Sushmitha, S, Akhila, Chagalamari, Ramu, Ramith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148593/
https://www.ncbi.nlm.nih.gov/pubmed/35655903
http://dx.doi.org/10.6026/97320630017932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148593/
https://www.ncbi.nlm.nih.gov/pubmed/35655903
http://dx.doi.org/10.6026/97320630017932

Ejemplares similares